Cargando…
Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms
OBJECTIVE: Accurate preoperative identification of benign or malignant pancreatic cystic neoplasms (PCN) may help clinicians make better intervention choices and will be essential for individualized treatment. METHODS: Preoperative ultrasound and laboratory examination findings, and demographic char...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630525/ https://www.ncbi.nlm.nih.gov/pubmed/36350006 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0258 |
_version_ | 1784823620991713280 |
---|---|
author | Wang, Xiuchao Wang, Junjin Wei, Xi Zhao, Lihui Ni, Bo Li, Zekun Gao, Chuntao Gao, Song Zhao, Tiansuo Wang, Jian Ma, Weidong Hu, Xiao Hao, Jihui |
author_facet | Wang, Xiuchao Wang, Junjin Wei, Xi Zhao, Lihui Ni, Bo Li, Zekun Gao, Chuntao Gao, Song Zhao, Tiansuo Wang, Jian Ma, Weidong Hu, Xiao Hao, Jihui |
author_sort | Wang, Xiuchao |
collection | PubMed |
description | OBJECTIVE: Accurate preoperative identification of benign or malignant pancreatic cystic neoplasms (PCN) may help clinicians make better intervention choices and will be essential for individualized treatment. METHODS: Preoperative ultrasound and laboratory examination findings, and demographic characteristics were collected from patients. Multiple logistic regression was used to identify independent risk factors associated with malignant PCN, which were then included in the nomogram and validated with an external cohort. The Net Reclassification Index (NRI) and Integrated Discrimination Improvement (IDI) were calculated to evaluate the improvement in the predictive power of the new model with respect to that of a combined imaging and tumor marker prediction model. RESULTS: Malignant PCN were found in 83 (40.7%) and 33 (38.7%) of the model and validation cohorts, respectively. Multivariate analysis identified age, tumor location, imaging of tumor boundary, blood type, mean hemoglobin concentration, neutrophil-to-lymphocyte ratio, carbohydrate antigen 19-9, and carcinoembryonic antigen as independent risk factors for malignant PCN. The calibration curve indicated that the predictions based on the nomogram were in excellent agreement with the actual observations. A nomogram score cutoff of 192.5 classified patients as having low vs. high risk of malignant PCN. The model achieved good C-statistics of 0.929 (95% CI 0.890–0.968, P < 0.05) and 0.951 (95% CI 0.903–0.998, P < 0.05) in predicting malignancy in the development and validation cohorts, respectively. NRI = 0.268; IDI = 0.271 (P < 0.001 for improvement). The DCA curve indicated that our model yielded greater clinical benefits than the comparator model. CONCLUSIONS: The nomogram showed excellent performance in predicting malignant PCN and may help surgeons select patients for detailed examination and surgery. The nomogram is freely available at https://wangjunjinnomogram.shinyapps.io/DynNomapp/. |
format | Online Article Text |
id | pubmed-9630525 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Compuscript |
record_format | MEDLINE/PubMed |
spelling | pubmed-96305252022-11-07 Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms Wang, Xiuchao Wang, Junjin Wei, Xi Zhao, Lihui Ni, Bo Li, Zekun Gao, Chuntao Gao, Song Zhao, Tiansuo Wang, Jian Ma, Weidong Hu, Xiao Hao, Jihui Cancer Biol Med Original Article OBJECTIVE: Accurate preoperative identification of benign or malignant pancreatic cystic neoplasms (PCN) may help clinicians make better intervention choices and will be essential for individualized treatment. METHODS: Preoperative ultrasound and laboratory examination findings, and demographic characteristics were collected from patients. Multiple logistic regression was used to identify independent risk factors associated with malignant PCN, which were then included in the nomogram and validated with an external cohort. The Net Reclassification Index (NRI) and Integrated Discrimination Improvement (IDI) were calculated to evaluate the improvement in the predictive power of the new model with respect to that of a combined imaging and tumor marker prediction model. RESULTS: Malignant PCN were found in 83 (40.7%) and 33 (38.7%) of the model and validation cohorts, respectively. Multivariate analysis identified age, tumor location, imaging of tumor boundary, blood type, mean hemoglobin concentration, neutrophil-to-lymphocyte ratio, carbohydrate antigen 19-9, and carcinoembryonic antigen as independent risk factors for malignant PCN. The calibration curve indicated that the predictions based on the nomogram were in excellent agreement with the actual observations. A nomogram score cutoff of 192.5 classified patients as having low vs. high risk of malignant PCN. The model achieved good C-statistics of 0.929 (95% CI 0.890–0.968, P < 0.05) and 0.951 (95% CI 0.903–0.998, P < 0.05) in predicting malignancy in the development and validation cohorts, respectively. NRI = 0.268; IDI = 0.271 (P < 0.001 for improvement). The DCA curve indicated that our model yielded greater clinical benefits than the comparator model. CONCLUSIONS: The nomogram showed excellent performance in predicting malignant PCN and may help surgeons select patients for detailed examination and surgery. The nomogram is freely available at https://wangjunjinnomogram.shinyapps.io/DynNomapp/. Compuscript 2022-10-15 2022-11-01 /pmc/articles/PMC9630525/ /pubmed/36350006 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0258 Text en Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0 (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Original Article Wang, Xiuchao Wang, Junjin Wei, Xi Zhao, Lihui Ni, Bo Li, Zekun Gao, Chuntao Gao, Song Zhao, Tiansuo Wang, Jian Ma, Weidong Hu, Xiao Hao, Jihui Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms |
title | Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms |
title_full | Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms |
title_fullStr | Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms |
title_full_unstemmed | Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms |
title_short | Preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms |
title_sort | preoperative ultrasound combined with routine blood tests in predicting the malignant risk of pancreatic cystic neoplasms |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9630525/ https://www.ncbi.nlm.nih.gov/pubmed/36350006 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0258 |
work_keys_str_mv | AT wangxiuchao preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms AT wangjunjin preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms AT weixi preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms AT zhaolihui preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms AT nibo preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms AT lizekun preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms AT gaochuntao preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms AT gaosong preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms AT zhaotiansuo preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms AT wangjian preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms AT maweidong preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms AT huxiao preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms AT haojihui preoperativeultrasoundcombinedwithroutinebloodtestsinpredictingthemalignantriskofpancreaticcysticneoplasms |